Two-year changes in blood pressure and subsequent risk of cardiovascular disease in men

Circulation

Volumn 102, Issue 3, 2000, Pages 307-312

  Sesso, Howard D ^a,c   Stampfer, Meir J ^a,c   Rosner, Bernard ^a   Gaziano, J Michael ^a,b,d   Hennekens, Charles H ^a,c,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d VA BOSTON HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Epidemiology; Heart diseases; Myocardial infarction; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0034682635     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.3.307     Document Type: Article

References (23)

1. Kannel WB. Risk factors in hypertension. J Cardiovasc Pharmacol. 1989;13:S4-S10.
2. Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
3. Hofman A. Change viewed on the level. Int J Epidemiol. 1983;12: 391-392.
4. Samuelsson O, Wilhelmsen L, Andersson OK, et al. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension: results from the primary prevention trial in Goteborg, Sweden. JAMA. 1987;258:1768-1776.
5. Hofman A, Feinleib M, Garrison RJ, et al. Does change in blood pressure predict heart disease? BMJ. 1983;287:267-269.
6. Farchi G, Capocaccia R, Verdecchia A, et al. Risk factors changes and coronary heart disease in an observational study. Int J Epidemiol. 1981; 10:31-40.
7. Millar JA, Lever AF. Blood pressure, change in blood pressure, and cardiovascular event rates in placebo-treated patients in the Medical Research Council Trial. J Cardiovasc Pharmacol. 1990;16:S89-S91.
8. Woodbury MA, Manton KG, Stallard E. A dynamic analysis of chronic disease development: a study of sex specific changes in coronary heart disease incidence and risk factors in Framingham. Int J Epidemiol. 1981; 10:355-366.
9. Tervahauta M, Pekkanen J, Enlund H, et al. Change in blood pressure and 5-year risk of coronary heart disease among elderly men: the Finnish cohorts of the Seven Countries Study. J Hypertens. 1994;12: 1183-1189.
10. Witteman JC, Grobbee DE, Valkenburg HA, et al. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet. 1994;343:504-507.
11. Vartiainen E, Puska P, Pekkanen J, et al. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ. 1994;309:23-27.
12. The Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989;321:129-135.
13. Klag MJ, He J, Mead LA, et al. Validity of physicians' self-reports of cardiovascular disease risk factors. Ann Epidemiol. 1993;3:442-447.
14. Ascherio A, Rimm EB, Giovannucci EL, et al. A prospective study of nutritional factors and hypertension among US men. Circulation. 1992; 86:1475-1484.
15. World Health Organization. Ischaemic heart Disease Registers: Report of the Fifth Working Group, Including a Second Revision of the Operating Protocol: Copenhagen, 26-29 April 1971. Copenhagen, Denmark: Regional Office for Europe, World Health Organization; 1971.
16. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149.
17. Carethers M, Blanchette PL. Pathophysiology of hypertension. Clin Geriatr Med. 1989;5:657-674.
18. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randemised trial: HOT study group. Lancet. 1998;351:1755-1762.
19. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
20. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease, part 2: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context, Lancet. 1990;335:827-838.
21. Cruickshank JM. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. BMJ. 1988;297: 1227-1230.
22. Paffenbarger RS, Wing AL, Hyde RT, et al. Physical activity and incidence of hypertension in college alumni. Am J Epidemiol. 1983;117: 245-257.
23. Haffner SM, Miettinen H, Gaskill SP, et al. Metabolic precursors of hypertension: the San Antonio Heart Study. Arch Intern Med. 1996;156: 1994-2000.